HP names former GSK chief Emma Walmsley as CEO

HP Inc. has unanimously appointed Emma Walmsley, who ran GSK from 2017 to 2025, as chief executive effective January 4, 2027, ending the interim tenure of Bruce Broussard, who becomes board chair.

Why it matters: The appointment closes a search running since Enrique Lores left in February and puts a consumer and pharmaceuticals operator, with seven years on Microsoft's board, in charge of a PC maker working through a memory chip cost crunch and an AI device transition.

Data as of HP Inc. announcement of November 4, 2026, read in full from the company's release in this run; all appointment terms are the company's own. The memory chip cost context is from Reuters reporting of the same announcement. Developing item.

HP Inc. said on Wednesday that its board unanimously appointed Emma Walmsley as chief executive officer, effective January 4, 2027. Walmsley ran the drugmaker GSK from April 2017 through December 2025, leading its separation of the consumer healthcare business, and has sat on Microsoft’s board for seven years; she succeeds Bruce Broussard, who has served as interim chief executive since February 2026, when Enrique Lores departed, and who will become chair of the board on the same date, succeeding Chip Bergh.

Walmsley takes over a PC and print business working through a memory chip crunch that has driven up prices across the industry, in Reuters’ framing of the announcement, and said she would focus on the AI era and new sources of growth. She has no prior record running a technology hardware company.

HP names former GSK chief Emma Walmsley as CEO

Sources